Response of Clostridium Difficile Infection to Metronidazole Therapy

Completed

Conditions studied: Clostridium Enterocolitis, Pseudomembranous Colitis, Antibiotic-Associated Colitis

In brief

In this record review study, our objective is to determine the rates of cure, failure and relapse following treatment of C. difficile colitis with metronidazole.

Key facts

Study ID

NCT00304369

Run by

Michael E. DeBakey VA Medical Center

People needed

290

Starts

2005-06-01

Expected to finish

2007-06-01

Last updated by the study team

2013-02-18

Who can join

Age: 18 and older, up to 64. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• records of patients who have a fecal sample positive for C. difficile toxin and who are then treated for C. difficile colitis with oral metronidazole will be included in this study.

You may not qualify if…

• Patients who did not receive at least 7 days of metronidazole

Where it is running

• Michael E. Debakey VA Medical Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.